Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Business Growth Plans: Diversifying Product Lines and Strengthening Technology Integration|Dhiraj Patel,Managing Director,Vikram Thermo (India) Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dhiraj Patel,Chaiman and Managing Director
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
CyanConnode's Robust Finances, Strategic Partnerships, and Promising Pipeline Propel Growth | John Cronin, Executive Chairman of cyanconnode holdings plc
00:10:00
Invests in early-stage investments in technology companies with conviction since 1970|Devdutt Yellurkar,General Partner,CRV
00:10:00
NewAlpha: From Seed Arrangement to Fund Closure in Hedge Fund Seeding
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:10:00
Vallourec Embraces Diversity and Inclusion: CEO Philippe Guillemot on International Women’s Day | Philippe Guillemot, CEO, Vallourec SA.
00:10:00
Financial Fitness Fundamentals: Tips from American Century Investments
00:10:00
Australia's No.1 rental property website|Greg Bader,Chief Executive Officer,Rent.com.au Ltd
00:10:00
Innovate Faster than Internet Giants|Hurst lin,General Partner, DCM
00:10:00
Telkom's profit more than halved due to declines in fixed, mobile, and IT services revenue in its latest six-month results.
00:10:00
GHL Systems Berhad: CEO and IR Director Briefing | SEAN S. HESH - Group Chief Executive Officer of GHL Systems Berhad
00:10:00
Henry Albrecht and Jack Smith Discuss Innovation at Startup Grind Eastside | Henry Albrecht, CEO , Limeade Inc.
00:10:00
Interview with OMEGA CEO Raynald Aeschlimann explores the future of the brand, lessons learned, and more insights into their vision.